Summary
Vitamin D and mineral metabolism status was examined in five children maintained chronically on combined ketogenic diet-anticonvulsant drug therapy (KG), and the results compared to those obtained in 18 patients treated with anticonvulsant drugs alone (AD) and 15 normal controls. KG patients exhibited biochemical findings of vitamin D deficiency osteomalacia: decreased serum 25-hydroxyvitamin D (25OHD) and calcium concentrations, elevated serum alkaline phosphatase and parathyroid hormone concentrations, decreased urinary calcium and increased urinary hydroxyproline excretion, and decreased bone mass. Although the KG and AD groups demonstrated similar reductions in serum 25OHD concentration, the KG patients exhibited a significantly greater reduction in bone mass. In response to vitamin D supplementation (5000 IU/day), mean bone mass in the KG group increased by 8.1±0.9% (P<0.001) over a 12-month period. These results suggest that ketogenic diet and anticonvulsant drug therapy have additive deleterious effects on bone mass and that these effects are partially reversible by vitamin D treatment.
Similar content being viewed by others
References
Huttenlocher, P.R.: Ketonemia and seizures: Metabolic and anticonvulsant effects of two ketogenic diets in childhood epilepsy, Pediatr. Res.10:536–540, 1976
DeVivo, D.C., Leckie, M.P., Ferrendelli, J.A., McDougal, D.B., Jr.: Chronic ketosis and cerebral metabolism, Ann. Neurol.3:331–337, 1978
DeVivo, D.C., Malas, K.M., Leckie, M.P.: Starvation and seizures: Observations on the electroconvulsive threshold and cerebral metabolism of the starved adult rat, Arch. Neurol.32:755–760, 1975
Bouillion, R., Reynault, J., Claes, J.G., Lissens, W., DeMoor, P.: The effect of anticonvulsant therapy on serum levels of 25-hydroxyvitamin D calcium and parathyroid hormone, J. Clin. Endocrinol. Metab.41:1130–1135, 1135, 1975
Dent, C.E., Richens, A., Rowe, D.J.F., Stamp, T.C.B.: Osteomalacia with long-term anticonvulsant therapy in epilepsy, Br. Med. J.4:69–72, 1970
Hahn, T.J., Hendin, B.A., Scharp, C.R., Boisseau, V.C., Haddad, J.G., Jr.: Serum 25-hydroxycalciferol levels and bone mass in children on chronic anticonvulsant therapy, N. Engl. J. Med.292:550–554, 1975
Jubiz, W., Haussler, M.R., McCain, T.A., Tolman, K.: Plasma 1,25-dihydroxyvitamin D levels in patients receiving anticonvulsant drugs, J. Clin Endocrinol. Metab.44:617–621, 1977
Lifshitz, F., Maclaren, N.K.: Vitamin D-dependent rickets in institutionalized, mentally retarded children receiving long-term anticonvulsant therapy: I. A survey of 288 patients, J. Pediatr.83:612–620, 1973
Richens, A., Rowe D.J.F.: Disturbance of calcium metabolism by anticonvulsant drugs, Br. Med. J.3:73–76, 1970
Tolman, K.G., Jubiz, W., Sannella, J.J., Madsen, J.A.: Osteomalacia associated with anticonvulsant drug therapy in mentally retarded children, Pediatrics56:45–51, 1975
Hahn, T.J., Birge, S.J., Scharp, C.R., Avioli, L.V.: Phenobarbital-induced alterations in vitamin D metabolism, J. Clin. Invest.51:741–748, 1972
Silver, J., Neale, G., Thompson, G.R.: Effect of phenobarbitone treatment on vitamin D metabolism in mammals, Clin. Sci. Mol. Med.46:433–448, 1974
Lemann, J., Jr., Litzow, J.R., Lennon, E.J.: The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis, J. Clin. Invest.45:1608–1614, 1966
Lee, S.W., Russell, J., Avioli, L.V.: 25-Hydroxycholecalciferol to 1,25-dihydroxycholecalciferol conversion impaired by systemic acidosis, Science195:994, 1977
DeVivo, D.C., Dahn, T.J.: Calcium-vitamin D metabolism and the ketogenic diet. Child Neurology Society Meeting, Charlottesville, Virginia-October 6–8, Ann. Neurol.2:255, 1977 (abst.)
Huttenlocher, P.R., Wilbourn, A.J., Signore, J.M.: Medium-chain triglycerides as a therapy for intractable childhood epilepsy, Neurology (Minneap.)21:1097–1103, 1971
Haddad, J.G., Jr., Chyu, K.G.: Competitive protein-binding radioassay for 25-hydroxycholecalciferol, J. Clin. Endocrinol. Metab.33:992–995, 1971
Slatopolsky, E., Cagbar, S., Pennell, J.P., Taggard, D.D., Canterbury, J.M., Reiss, E., Bricker, N.: On the pathogeneses of hyperparathyroidism in chronic experimental renal insufficiency in the dog, J. Clin. Invest.50:492–499, 1971
Prockop, D.J., Udenfriend, S.: A specific method for the analysis of hydroxyproline in tissues and urine, Anal. Biochem.1:228–239, 1960
DeVivo, D.C., Haymond, M.W., Leckie, M.P., Bussmann, Y.L., McDougal, D.B., Jr., Pagliara, A.S.: The clinical and biochemical implications of pyruvate carboxylase deficiency, J. Clin. Endocrinol. Metab.45:1281–1296, 1977
Hahn, T.J., Boisseau, V.C., Avioli, L.V.: Effect of chronic corticosteroid administration on diaphyseal and metaphyseal bone mass, J. Clin. Endocrinol. Metab.39:274–282, 1974
Snedecor, G.W.: Analyses of variance. In G.W. Snedecor (ed.): Statistical Methods, 5th Ed., pp. 237–290. Iowa State University Press, Ames, Iowa, 1956
Lassiter, W.E., Gottschalk, C.W., Mylle, M.: Micropuncture study of renal tubular reabsorption of calcium in normal rodents, Am. J. Physiol.204:771–775, 1963
Klein, L., Lafferty, F.W., Pearson, O.H., Curtiss, P.H., Jr.: Correlation of urinary hydroxyproline, serum alkaline phosphatase and skeletal calcium turnover, Metabolism13:272–284, 1964
Haddad, J.G., Jr., Couranz, S., Avioli, L.V.: Nondialyzable urinary hydroxyproline as an index of bone collagen formation, J. Clin. Endocrinol. Metab.30:282–287, 1970
Sjoerdsma, A., Udenfriend, S., Deisser, H., LeRoy, H.C.: Hydroxyproline and collagen metabolism. Clinical implications, Ann. Intern. Med.63:672–694, 1965.
Glorieux, F.H., Delvin, E.E., Dussault, M.: Evaluation of liver hydroxylation of vitamin D by simultaneous measurement of circulating cholecalciferol and 25-hydroxycholecalciferol. Trans. 22nd Annual Meeting, Orthop. Res. Soc.1:123–128, 1976
Koch, H.V., Kraft, D., von Herrath, D., et al.: AL.: Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat, Epilepsia13:829–841, 1972
Jenkins, M.V., Harris, M., Willis, M.R.: The effect of phenytoin on parathyroid extract and 25-hydroxycholecalciferol-induced bone resorption: adenosine 3′5′ cyclic monophosphate production, Calcif. Tissue Res.16:163–167, 1974
Hahn, T.J., Scharp, C.R., Richardson, C.A., Halstead, L.R., Kahn, A.J., Teitelbaum, S.L.: Interaction of diphenylhydantoin and phenobarbital with hormonal mediation of fetal rat bone resorptionin vitro, J. Clin. Invest.62:406–414, 1978
Christiansen, C., Rodbro, P., Lund, P.: Incidence of anti-convulsant osteomalacia and effect of vitamin D: controlled therapeutic trial, Br. Med. J.4:695–701, 1973
Christiansen, C., Rodbro, P., Nielson, C.T.: Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial, Acta Paediatr. Scand.64:219–224, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hahn, T.J., Halstead, L.R. & DeVivo, D.C. Disordered mineral metabolism produced by ketogenic diet therapy. Calcif Tissue Int 28, 17–22 (1979). https://doi.org/10.1007/BF02441213
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02441213